Bank of New York Mellon Corp cut its stake in Healthpeak Properties, Inc. (NYSE:PEAK) by 1.1% in the second quarter, HoldingsChannel reports. The institutional investor owned 6,403,866 shares of the company’s stock after selling 72,083 shares during the quarter. Bank of New York Mellon Corp’s holdings in Healthpeak Properties were worth $213,183,000 at the end of the most recent reporting period.
A number of other institutional investors also recently modified their holdings of PEAK. Certified Advisory Corp purchased a new position in Healthpeak Properties in the first quarter valued at about $28,000. E Fund Management Co. Ltd. purchased a new position in shares of Healthpeak Properties during the 1st quarter worth approximately $30,000. Ameritas Investment Company LLC purchased a new position in shares of Healthpeak Properties during the 1st quarter worth approximately $30,000. Disciplined Investments LLC purchased a new position in shares of Healthpeak Properties during the 2nd quarter worth approximately $48,000. Finally, Credit Agricole S A increased its stake in shares of Healthpeak Properties by 159.9% during the 2nd quarter. Credit Agricole S A now owns 1,484 shares of the company’s stock worth $49,000 after purchasing an additional 913 shares in the last quarter. 92.79% of the stock is owned by institutional investors.
Shares of PEAK opened at $34.04 on Friday. The firm has a market cap of $18.35 billion, a PE ratio of 36.60, a price-to-earnings-growth ratio of 4.79 and a beta of 0.69. The company’s fifty day moving average is $35.76 and its two-hundred day moving average is $34.16. Healthpeak Properties, Inc. has a fifty-two week low of $25.75 and a fifty-two week high of $37.69. The company has a quick ratio of 1.01, a current ratio of 1.01 and a debt-to-equity ratio of 0.68.
A number of brokerages have recently weighed in on PEAK. Mizuho reissued a “neutral” rating and set a $32.00 price objective on shares of Healthpeak Properties in a research note on Wednesday, July 14th. Wells Fargo & Company raised their price objective on shares of Healthpeak Properties from $32.00 to $36.00 and gave the stock an “underweight” rating in a research note on Friday, July 23rd. Morgan Stanley raised their price objective on shares of Healthpeak Properties from $32.00 to $37.00 and gave the stock an “equal weight” rating in a research note on Monday, September 13th. Royal Bank of Canada raised their target price on shares of Healthpeak Properties from $36.00 to $39.00 and gave the stock an “outperform” rating in a research report on Tuesday, August 17th. Finally, Argus raised their target price on shares of Healthpeak Properties from $34.00 to $39.00 and gave the stock a “buy” rating in a research report on Tuesday, June 15th. One analyst has rated the stock with a sell rating, four have issued a hold rating and seven have given a buy rating to the company’s stock. According to data from MarketBeat.com, the company presently has an average rating of “Buy” and an average target price of $34.85.
About Healthpeak Properties
Healthpeak Properties, Inc is a real estate investment trust, which invests primarily in real estate serving the healthcare industry in the United States. It acquires, develops, leases, sells, and manages healthcare real estate and provides mortgage and other financing to healthcare providers. It operates through the following business segments: Life Science, Medical Office and Continuing Care Retirement Community(CCRC).
Featured Article: What is the accumulation/distribution indicator?
Want to see what other hedge funds are holding PEAK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Healthpeak Properties, Inc. (NYSE:PEAK).
Receive News & Ratings for Healthpeak Properties Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthpeak Properties and related companies with MarketBeat.com's FREE daily email newsletter.